These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 28441386)

  • 1. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study.
    Schütz E; Fischer A; Beck J; Harden M; Koch M; Wuensch T; Stockmann M; Nashan B; Kollmar O; Matthaei J; Kanzow P; Walson PD; Brockmöller J; Oellerich M
    PLoS Med; 2017 Apr; 14(4):e1002286. PubMed ID: 28441386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation.
    Oellerich M; Schütz E; Kanzow P; Schmitz J; Beck J; Kollmar O; Streit F; Walson PD
    Ther Drug Monit; 2014 Apr; 36(2):136-40. PubMed ID: 24452066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury.
    Beck J; Bierau S; Balzer S; Andag R; Kanzow P; Schmitz J; Gaedcke J; Moerer O; Slotta JE; Walson P; Kollmar O; Oellerich M; Schütz E
    Clin Chem; 2013 Dec; 59(12):1732-41. PubMed ID: 24061615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-Derived Cell-Free DNA Is a Novel Universal Biomarker for Allograft Rejection in Solid Organ Transplantation.
    Beck J; Oellerich M; Schulz U; Schauerte V; Reinhard L; Fuchs U; Knabbe C; Zittermann A; Olbricht C; Gummert JF; Shipkova M; Birschmann I; Wieland E; Schütz E
    Transplant Proc; 2015 Oct; 47(8):2400-3. PubMed ID: 26518940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-Derived Cell-Free DNA as a Marker of Transplant Graft Injury.
    Oellerich M; Walson PD; Beck J; Schmitz J; Kollmar O; Schütz E
    Ther Drug Monit; 2016 Apr; 38 Suppl 1():S75-9. PubMed ID: 26418703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.
    Zou J; Duffy B; Slade M; Young AL; Steward N; Hachem R; Mohanakumar T
    Hum Immunol; 2017 Apr; 78(4):342-349. PubMed ID: 28267558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
    Park S; Guo K; Heilman RL; Poggio ED; Taber DJ; Marsh CL; Kurian SM; Kleiboeker S; Weems J; Holman J; Zhao L; Sinha R; Brietigam S; Rebello C; Abecassis MM; Friedewald JJ
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1539-1551. PubMed ID: 34620649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.
    Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J
    Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of fragment size distribution of cell-free DNA: A potential non-invasive marker to monitor graft damage in living-related liver transplantation for inborn errors of metabolism.
    Ng HI; Zhu X; Xuan L; Long Y; Mao Y; Shi Y; Sun L; Liang B; Scaglia F; Choy KW; Zhu Z
    Mol Genet Metab; 2019 May; 127(1):45-50. PubMed ID: 31027872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive graft monitoring using donor-derived cell-free DNA in Japanese liver transplantation.
    Kanamori H; Yamada Y; Ito Y; Shirosaki K; Yamagishi S; Maeda Y; Kudo Y; Umeyama T; Takahashi N; Kato M; Hasegawa Y; Matsubara K; Shinoda M; Obara H; Irie R; Tsujikawa H; Okita H; Nguyen PT; Saigo K; Mitsunaga S; Inoue I; Kitagawa Y; Kuroda T
    Hepatol Res; 2024 Mar; 54(3):300-314. PubMed ID: 37850337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Universal Droplet Digital PCR Approach for Monitoring of Graft Health After Transplantation Using a Preselected SNP Set.
    Beck J; Oellerich M; Schütz E
    Methods Mol Biol; 2018; 1768():335-348. PubMed ID: 29717452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Postoperative Graft-Derived Cell-Free DNA to Evaluate the Risks of Impaired Allograft Function at Early Stage of Kidney Transplantation.
    Yang H; Hou Y; Liang T; Lan Y; He J; Lu J; Wei L
    Transplant Proc; 2022 Oct; 54(8):2159-2164. PubMed ID: 36369141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation.
    Raschzok N; Reutzel-Selke A; Schmuck RB; Morgul MH; Gauger U; Prabowo KA; Tannus LM; Leder A; Struecker B; Boas-Knoop S; Bartels M; Jonas S; Lojewski C; Puhl G; Seehofer D; Bahra M; Pascher A; Pratschke J; Sauer IM
    Liver Transpl; 2015 Sep; 21(9):1195-207. PubMed ID: 25950774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
    J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding Factors.
    Knüttgen F; Beck J; Dittrich M; Oellerich M; Zittermann A; Schulz U; Fuchs U; Knabbe C; Schütz E; Gummert J; Birschmann I
    Transplantation; 2022 Mar; 106(3):615-622. PubMed ID: 33653997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients.
    Zhao D; Zhou T; Luo Y; Wu C; Xu D; Zhong C; Cong W; Liu Q; Zhang J; Xia Q
    Sci Rep; 2021 Jan; 11(1):1138. PubMed ID: 33441886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of BK polyomavirus-associated nephropathy using plasma graft-derived cell-free DNA: Development of a novel algorithm from programmed monitoring.
    Wen J; Sun R; Yang H; Ran Q; Hou Y
    Front Immunol; 2022; 13():1006970. PubMed ID: 36275762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT).
    DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR
    J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.